Merck & Co. target price raised to $180 from $150 by Barclays
MRK•Barclays raised its target price for Merck & Co. to $180 from $150.
Related News
Methanex Corporation: Raymond James raises target price to $72 from $65
MEOH•
Political dollar risks aren't going anywhere after midterms: Commerzbank
SPY•
Mercury Systems EVP, CLO and corporate secretary Stuart Kupinsky sells $76,000 in common shares
MRCY•
Medicus Pharma regains compliance with Nasdaq minimum bid price requirement
MDCX•
NAPCO Security Technologies publishes update to financial calendar
NSSC•